IP Library › Granted Patent US 11,155,877
Granted Patent B2
US 11,155,877 · App. 16/165,400 · Granted Oct 26, 2021

Nucleic acid detection combining amplification with fragmentation

Inventors: Heather R. Sanders (RSM, CA); Kevin Z. Qu (Lake Forest, CA); Charles M. Strom (San Clemente, CA); Richard A. Bender (Dana Point, CA)
Assignee: Quest Diagnostics Investments LLC
C12Q1/6886C12Q1/6806C12Q2600/118C12Q2600/156C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,155,877
App. No.
16/165,400
Granted
Oct 26, 2021
Kind
B2
Abstract

Provided herein are methods and compositions for detection of a nucleic acid target in a sample. The methods and compositions use primer directed amplification in conjunction with nucleic acid fragmentation. The methods have high sensitivity even in the presence of a large amount of non-target nucleic acid. Also provided are oligonucleotides and kits useful in the method. Exemplary nucleic acid targets are those with mutant gene sequence such as mutant sequence of the EGFR, APC, TMPRSS2, ERG and ETV1 genes.

Claims (18)

1. A kit comprising:

an oligonucleotide primer pair comprising a forward primer of SEQ NO:1 and a reverse primer of SEQ NO:2 and restriction enzyme MseI;

an oligonucleotide primer pair comprising a forward primer of SEQ NO:3 and a reverse primer of SEQ NO:4 and restriction enzyme Mn1I;

an oligonucleotide primer pair comprising a forward primer of SEQ NO:5 and a reverse primer of SEQ NO:6 and restriction enzyme Mn1I;

an oligonucleotide primer pair comprising a forward primer of SEQ NO:7 and a reverse primer of SEQ NO:8 and at least one restriction enzyme selected from MscI or EaeI, or a combination thereof;

an oligonucleotide primer pair comprising a forward primer of SEQ NO:9 and a reverse primer of SEQ NO:10 and restriction enzyme FatI;

an oligonucleotide primer pair comprising a forward primer of SEQ NO:11 and a reverse primer of SEQ NO:12 and restriction enzyme HpyCH4VI; or

a combination thereof;

at least one oligonucleotide of the primer pair is labeled with a detectable moiety.

2. The kit of claim 1 , wherein the detectable moiety is a fluorescent dye.

3. The kit of claim 1 , wherein different pairs of primers in the kit are labeled with different distinguishable detectable moieties.

4. The kit of claim 1 , wherein the at least one primer pair comprises a forward primer and a reverse primer labeled with different detectable moieties.

5. The kit of claim 1 , wherein the kit comprises the oligonucleotide primer pair SEQ ID NOs: 1 and 2 and the restriction enzyme MseI.

6. The kit of claim 1 , wherein the kit comprises the oligonucleotide primer pair SEQ ID NOs: 3 and 4 and the restriction enzyme Mn1I.

7. The kit of claim 1 , wherein the kit comprises the oligonucleotide primer pair SEQ ID NOs: 5 and 6 and the restriction enzyme Mn1I.

8. The kit of claim 1 , wherein the kit comprises the oligonucleotide primer pair SEQ ID NOs: 7 and 8 and the restriction enzyme MscI or EaeI, or a combination thereof.

9. The kit of claim 1 , wherein the kit comprises the oligonucleotide primer pair SEQ ID NOs: 9 and 10 and the restriction enzyme FatI.

10. The kit of claim 1 , wherein the kit comprises the oligonucleotide primer pair SEQ ID NOs: 11 and 12 and the restriction enzyme HpyCH4VI.

Continuity (6)
Continuation 15712448 · Sep 22, 2017
Division 14679403 · Apr 6, 2015
Continuation 12035356 · Feb 21, 2008
Provisional Application 61007928 · Jun 8, 2007
Provisional Application 60926611 · Apr 27, 2007
Related Publication 20190100808A1 · Apr 4, 2019
Cited By (1)
US 12,393,660